Clinical Trial Update: Role of 'Pentoxifylline and or IgM Enriched Intravenous Immunoglobulin in the Treatment of Neonatal Sepsis' [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 study evaluating pentoxifylline and/or IgM-enriched intravenous immunoglobulin in the treatment of neonatal sepsis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Sepsis

Drugs mentioned

• IgM-enriched intravenous immunoglobulin (IgM-enriched intravenous immunoglobulin)
• Pentoxifylline (pentoxifylline)

Snippet

Sponsor: Zekai Tahir Burak Women's Health Research and Education Hospital | Conditions: Sepsis of the Newborn | Phase 4 | Status: UNKNOWN